| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.21 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.17 | 0.007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.085 | 0.2 |